Truist initiated coverage on Tandem Diabetes Care with a new price target
$TNDM
Medical/Dental Instruments
Health Care
Truist initiated coverage of Tandem Diabetes Care with a rating of Hold and set a new price target of $24.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/16/2025 | $24.00 | Hold | Truist |
| 4/10/2025 | $20.00 | Neutral | Mizuho |
| 3/5/2025 | $45.00 → $22.00 | Overweight → Equal-Weight | Morgan Stanley |
| 3/4/2025 | $35.00 → $24.00 | Buy → Neutral | Citigroup |
| 3/3/2025 | $38.00 → $22.00 | Overweight → Equal Weight | Wells Fargo |
| 2/28/2025 | $35.00 → $25.00 | Outperform → Mkt Perform | Bernstein |
| 12/2/2024 | $45.00 | Equal-Weight → Overweight | Morgan Stanley |
| 11/6/2024 | $42.00 | Outperform | Bernstein |